Tag: Pharmaceutical | Page 127 | NAI 500 | Page 127

- English
  - 简体中文
  - 繁體中文

Home
Pharmaceutical

Filter

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

Jan 9, 2018

Simcere Acquires China Rights to Three Bi-Specific Immunoncology Drugs

Jan 8, 2018

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药，生物科技

Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement

Jan 8, 2018

Zhejiang DTRM Completes $60 Million A Round for US-China Clinical Trials

Jan 5, 2018

Jiangsu Hengrui Out-Licenses Novel Dermatology Drug for $233 Million

Jan 5, 2018

Miracor Closes $30 Million D Round, Led by Shenzhen’s Ming Capital

Jan 4, 2018

Genostics Invests $13.5 Million in UK’s Oncimmune for China Rights to Lung Cancer Test

Jan 4, 2018

Illumina Collaborates with KingMed on China Oncology IVD Assays

Jan 4, 2018

iCarbonX Leads $200 Million Funding in SomaLogic of Colorado

Jan 4, 2018

Hong Kong’s Xinogen Acquires China Rights to Angiochem Cancer Drug

Jan 3, 2018

ApolloBio and Inovio Alter $43 Million China Deal for HPV Immunotherapy

Jan 3, 2018

Perennial Real Estate Announces $1.2 Billion China Healthcare Center JV

Jan 3, 2018

Laviana Pharma Closes $15 Million Financing for China CRO/CMO Services

Jan 2, 2018

CMAB, a Suzhou Biologic CRO/CMO, Completes $38 Million A Round

Jan 2, 2018

Sansure Biotech Raises $77 Million in Funding Led by Lilly Asia

Jan 2, 2018

Sirona Biochem Announces SGLT2 IND Submission Milestone

Dec 29, 2017

CStone’s Anti-CTLA-4 Antibody CS1002 Filed for Clinical Trial Approval in Australia

Dec 29, 2017

Bioengineers mimic natural development to create complex living tissues

Dec 29, 2017